Ischemic Stroke: Basic Pathophysiology and Neuroprotective Strategies

Over the last two decades, basic science research in the field of stroke has elucidated multiple pathways of cellular injury and repair after cerebral ischemia, resulting in the identification of several promising targets for neuroprotection [1]. A large number of neuroprotective agents have been shown to reduce stoke-related damage in animal models. To date, however, no single agent has achieved success in clinical trials. Nevertheless, analysis of the reasons behind the failure of recent drug trials, combined with the success of clot-lysing drugs in improving clinical outcome, has revealed new potential therapeutic opportunities and raised expectations that successful stroke treatment will be achieved in the near future. In this chapter, we first highlight the major mechanisms of neuronal injury, emphasizing those that are promising targets for stroke therapy. We then discuss the influence of these pathways on white matter injury, and briefly review the emerging concept of the neurovascular unit. Finally, we review emerging strategies for the treatment of acute ischemic stroke.

[1]  F. Buonanno,et al.  A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.

[2]  F. Cheng,et al.  Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. , 2002, Life sciences.

[3]  J. Stamler,et al.  Mechanism of covalent modification of glyceraldehyde‐3‐phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents , 1994, FEBS letters.

[4]  O. Witte,et al.  Cortical Spreading Depression Induces Proinflammatory Cytokine Gene Expression in the Rat Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  L Persson,et al.  The Effect of MK-801 on Cortical Spreading Depression in the Penumbral Zone following Focal Ischaemia in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[7]  V. Perry,et al.  Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  P. Chan Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  E. Connolly,et al.  Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.

[10]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Baron,et al.  Mapping the ischaemic penumbra with PET: a new approach. , 2001, Brain : a journal of neurology.

[12]  J. Baron,et al.  Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications , 2001, Cerebrovascular Diseases.

[13]  G. Feuerstein,et al.  Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. , 1987, Stroke.

[14]  R. Busto,et al.  Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.

[15]  John H. Zhang,et al.  Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model , 2002, Brain Research.

[16]  M. Biros,et al.  Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. , 2001, Journal of neurosurgery.

[17]  H. Diener,et al.  Organization of Stroke Care: Education, Referral, Emergency Management and Imaging, Stroke Units and Rehabilitation , 2003, Cerebrovascular Diseases.

[18]  A. Thiel,et al.  Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. , 2001, Brain : a journal of neurology.

[19]  Günther Deuschl,et al.  Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats , 2004, Stroke.

[20]  M. Ross,et al.  Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Salvesen A lysosomal protease enters the death scene. , 2001, The Journal of clinical investigation.

[22]  S. Campbell,et al.  Reduction of excitotoxicity and associated leukocyte recruitment by a broad‐spectrum matrix metalloproteinase inhibitor , 2004, Journal of neurochemistry.

[23]  Voon Wee Yong,et al.  Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.

[24]  N. Wahlgren,et al.  Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .

[25]  John H. Zhang,et al.  Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion , 2001, Brain Research.

[26]  W. Hacke,et al.  Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke , 2003, Stroke.

[27]  Tatsuro Mori,et al.  Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—Reperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  G. Hankey,et al.  Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results , 2002, Stroke.

[29]  M. Fisher Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 , 2003, Stroke.

[30]  M. Kirk,et al.  Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study , 2003, Stroke.

[31]  M. Ginsberg,et al.  On ischemic brain injury in genetically altered mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[32]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[33]  O. Sakowitz,et al.  Spreading depolarizations occur in human ischemic stroke with high incidence , 2008, Annals of neurology.

[34]  P. Nicotera,et al.  Energy Requirement for Caspase Activation and Neuronal Cell Death , 2000, Brain pathology.

[35]  T. Coleman,et al.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. , 2000, Blood.

[36]  G. Zoppo Why do all drugs work in animals but none in stroke patients ? 1 Drugs promoting cerebral blood flow , 1995 .

[37]  C. Maier,et al.  Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke , 2002, Neuroscience.

[38]  W. Hacke,et al.  Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. , 1998, Stroke.

[39]  B. Dunn,et al.  Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. , 2009, Stroke.

[40]  E. Lo,et al.  Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.

[41]  M. Moskowitz,et al.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Bennett,et al.  Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Aburatani,et al.  Genome-Wide Gene Expression Analysis for Induced Ischemic Tolerance and Delayed Neuronal Death following Transient Global Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  P. Huang,et al.  Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice , 2001, Neuroscience.

[45]  T. Oury,et al.  Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia , 1999, Neuroscience.

[46]  L. Wilkins Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[47]  R. Sobel,et al.  Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[49]  Robert M Friedlander,et al.  Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.

[50]  K. Sunami,et al.  Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery , 2000, Critical care medicine.

[51]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[52]  J. Zivin,et al.  Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. , 1991, Archives of neurology.

[53]  P. Lyden,et al.  The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T) , 2001, Neurology.

[54]  P. Stys,et al.  Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  D. Stein,et al.  Mild hypothermia: therapeutic window after experimental cerebral ischemia. , 1996, Neurosurgery.

[56]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[57]  B. Kristal,et al.  An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[59]  J. Garcìa,et al.  Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. , 1995, Stroke.

[60]  Klaas Nicolay,et al.  Correlation between tissue depolarizations and damage in focal ischemic rat brain 1 Published on the World Wide Web on 12 July 1999. 1 , 1999, Brain Research.

[61]  H. Diener,et al.  Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.

[62]  G. Boysen,et al.  Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model , 1993, Journal of the Neurological Sciences.

[63]  C. Moy,et al.  The Albumin in Acute Stroke Trial (ALIAS); Design and Methodology , 2007, International journal of stroke : official journal of the International Stroke Society.

[64]  P. Carmeliet,et al.  Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[65]  N. Rothwell,et al.  Role of IL-1α and IL-1β in Ischemic Brain Damage , 2001, The Journal of Neuroscience.

[66]  M. Cuzner,et al.  Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.

[67]  Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice , 2001, Neuroscience Letters.

[68]  J. Mcdonald,et al.  Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.

[69]  M. A. Jacobs,et al.  Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke , 2004, Neuroradiology.

[70]  D. Choi,et al.  Reducing calcium overload in the ischemic brain. , 1999, The New England journal of medicine.

[71]  S. Lipton,et al.  Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  D. Choi,et al.  Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia , 1996, Brain Research.

[73]  H. Nawashiro,et al.  TNF-α Pretreatment Induces Protective Effects against Focal Cerebral Ischemia in Mice , 1997 .

[74]  S. Chandler,et al.  Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.

[75]  S. Bernard,et al.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.

[76]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[77]  T. Wieloch,et al.  Hypothermia Prevents the Ischemia‐Induced Translocation and Inhibition of Protein Kinase C in the Rat Striatum , 1991, Journal of neurochemistry.

[78]  V. Wee Yong,et al.  Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.

[79]  M. Moskowitz,et al.  Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  M. Moskowitz,et al.  Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[81]  D. Liebeskind,et al.  Trends in Acute Ischemic Stroke Trials Through the 20th Century , 2001, Stroke.

[82]  M. Ginsberg,et al.  The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.

[83]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[84]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[85]  M. Chopp,et al.  Journal of Cerebral Blood Flow and Metabolism Temperature Modulation of Cerebral Depolarization during Focal Cerebral Ischemia in Rats: Correlation with Ischemic Injury , 2022 .

[86]  M. Fini,et al.  Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[87]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[88]  D. J. Cole,et al.  Focal Cerebral Ischemia in Rats: Effects of Induced Hypertension, during Reperfusion, on CBF , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[89]  A. Villringer,et al.  Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning the Human Brain?: A Multicenter Magnetic Resonance Imaging Study , 2004, Stroke.

[90]  J. Seylaz,et al.  Reduction of Infarct Volume by Magnesium after Middle Cerebral Artery Occlusion in Rats , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[91]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[92]  E. Lo,et al.  Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[93]  T. Yamashima Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates , 2000, Progress in Neurobiology.

[94]  J. Grotta Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy , 1995, Journal of internal medicine.

[95]  John Whitehead,et al.  Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial , 2000, The Lancet.

[96]  P. Lyden,et al.  Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate Antagonist , 2000, Experimental Neurology.

[97]  G. Mealing,et al.  Novel Injury Mechanism in Anoxia and Trauma of Spinal Cord White Matter: Glutamate Release via Reverse Na+-dependent Glutamate Transport , 1999, The Journal of Neuroscience.

[98]  P. Bernardi,et al.  A mitochondrial perspective on cell death. , 2001, Trends in biochemical sciences.

[99]  M. Fini,et al.  Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. , 2002, Journal of neurotrauma.

[100]  D. Liebeskind,et al.  Reversing Stroke in the 2010s Lessons From Desmoteplase In Acute ischemic Stroke-2 (DIAS-2) CT and MRI approaches , 2009 .

[101]  M. Fisher,et al.  A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. , 2000, Acta neurochirurgica. Supplement.

[102]  G. Mies,et al.  Repeated Negative DC Deflections in Rat Cortex following Middle Cerebral Artery Occlusion are Abolished by MK-801: Effect on Volume of Ischemic Injury , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[103]  G. Donnan,et al.  Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. , 2004, Brain : a journal of neurology.

[104]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[105]  Taku Sugawara,et al.  Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[106]  S. Snyder,et al.  Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.

[107]  E. Lo,et al.  Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats , 2002, Stroke.

[108]  D. Tanné,et al.  Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort , 2002, Stroke.

[109]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[110]  S. Mohand-Said,et al.  Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2 , 2002, The Journal of Neuroscience.

[111]  F. Buonanno,et al.  Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.

[112]  S. Warach,et al.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.

[113]  N. Plesnila,et al.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[114]  K. Mikoshiba,et al.  ‘Ischemic tolerance’ phenomenon found in the brain , 1990, Brain Research.

[115]  S. Yusuf MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[116]  W. Hacke,et al.  Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. , 1999, Neurology.

[117]  M. Limburg,et al.  Calcium Antagonists for Ischemic Stroke: A Systematic Review , 2001, Stroke.

[118]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[119]  Enlimomab Acute Stroke Trial Investigators Use of anti-ICAM-1 therapy in ischemic stroke , 2001, Neurology.

[120]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[121]  J. Koziol,et al.  Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix , 2004, Stroke.

[122]  David A Boas,et al.  Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. , 2007, Brain : a journal of neurology.

[123]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[124]  Á. Chamorro,et al.  Neutrophil Infiltration Increases Matrix Metalloproteinase-9 in the Ischemic Brain after Occlusion/Reperfusion of the Middle Cerebral Artery in Rats , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[125]  G. Boysen,et al.  Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. , 1999, Stroke.

[126]  J. Alger,et al.  Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.

[127]  I. Herr,et al.  CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.

[128]  E. Michaelis Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging , 1998, Progress in Neurobiology.

[129]  P. Adeleine,et al.  Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. , 1995, Stroke.

[130]  E. Lo,et al.  Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[131]  A E Hillis,et al.  Restoring blood pressure reperfused Wernicke’s area and improved language , 2001, Neurology.

[132]  M. Bennett,et al.  Knockdown of AMPA Receptor GluR2 Expression Causes Delayed Neurodegeneration and Increases Damage by Sublethal Ischemia in Hippocampal CA1 and CA3 Neurons , 1999, The Journal of Neuroscience.

[133]  M. Chopp,et al.  DNA damage and repair in central nervous system injury: National Institute of Neurological Disorders and Stroke Workshop Summary. , 1996, Stroke.

[134]  Scott Hamilton,et al.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.

[135]  R. Busto,et al.  Lipid Peroxidation In Vivo Induced by Reversible Global Ischemia in Rat Brain , 1984, Journal of neurochemistry.

[136]  Alex Rovira,et al.  Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[137]  M. Ginsberg Hypothermic Neuroprotection in Cerebral Ischemia , 1997 .

[138]  M. Woodward,et al.  Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.

[139]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[140]  Astrid A. Ortiz,et al.  Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels , 2001, Nature Medicine.

[141]  G. Steinberg,et al.  Mild Hypothermia Attenuates Cytochrome C Release but Does Not Alter Bcl-2 Expression or Caspase Activation after Experimental Stroke , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[142]  A. Sorensen,et al.  Stability of large diffusion/perfusion mismatch in anterior circulation strokes for 4 or more hours , 2010, BMC neurology.

[143]  B R Rosen,et al.  Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.

[144]  J. Toole,et al.  Oxygen therapy in ischemic stroke. , 2003, Stroke.

[145]  K. Rajamani,et al.  Stroke precipitated by moderate blood pressure reduction. , 2000, The Journal of emergency medicine.

[146]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[147]  T. Olsen,et al.  Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study: The Copenhagen Stroke Study , 2000, Stroke.

[148]  U. Dirnagl,et al.  Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? , 1999, Stroke.

[149]  D. Krieger,et al.  Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? , 2004, Stroke.

[150]  Fuhai Li,et al.  Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. , 1999, Stroke.

[151]  M. Chao,et al.  Oligodendrocyte Apoptosis Mediated by Caspase Activation , 1999, The Journal of Neuroscience.

[152]  B. Mattsson,et al.  Rapid disappearance of zinc positive terminals in focal brain ischemia , 1998, Brain Research.

[153]  M. Moskowitz,et al.  Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.

[154]  Sandra E. Ford,et al.  A pilot study of hyperbaric oxygen in the treatment of human stroke. , 1991, Stroke.

[155]  Ulrich Dirnagl,et al.  Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage , 2009, Brain : a journal of neurology.

[156]  E. Lo,et al.  Drug delivery to damaged brain , 2001, Brain Research Reviews.

[157]  G L Wolf,et al.  Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. , 1998, AJNR. American journal of neuroradiology.

[158]  J. Beilby,et al.  Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis , 2004, Stroke.

[159]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[160]  Hans-Christoph Diener,et al.  NXY-059 for the treatment of acute ischemic stroke. , 2007, The New England journal of medicine.

[161]  B. Meldrum,et al.  Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. , 2000, Stroke.

[162]  J. Astrup,et al.  Inhibition of Cerebral Oxygen and Glucose Consumption in the Dog by Hypothermia, Pentobarbital, and Lidocaine , 1981, Anesthesiology.

[163]  M. Moskowitz,et al.  The ischemic cascade and mediators of ischemic injury. , 2009, Handbook of clinical neurology.

[164]  M. Nedergaard,et al.  Brain ion homeostasis in cerebral ischemia. , 1988, Neurochemical pathology.

[165]  S. Terakawa,et al.  Tissue-Type Plasminogen Activator is Involved in the Process of Neuronal Death Induced by Oxygen–Glucose Deprivation in Culture , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[166]  C. Sommer,et al.  Neuroprotection by Hyperbaric Oxygenation After Experimental Focal Cerebral Ischemia Monitored by MRI , 2004, Stroke.

[167]  M. Fujimura,et al.  Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[168]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[169]  G. Fiskum Mitochondrial participation in ischemic and traumatic neural cell death. , 2000, Journal of neurotrauma.

[170]  R. Crowell,et al.  Beneficial effects of induced hypertension on experimental stroke in awake monkeys. , 1984, Journal of neurosurgery.

[171]  AndrewJ. S. Coats MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[172]  Ulrich Dirnagl,et al.  Ischemic tolerance and endogenous neuroprotection , 2003, Trends in Neurosciences.

[173]  K. Liu,et al.  Interstitial pO2 in Ischemic Penumbra and Core are Differentially Affected following Transient Focal Cerebral Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[174]  K. Welch Primer on cerebrovascular diseases , 1997 .

[175]  R. Morrison,et al.  bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro. , 1996, Neuroreport.

[176]  K. Lees,et al.  A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. , 1995, Stroke.

[177]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[178]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[179]  J. Toole,et al.  Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats , 2000, Brain Research.

[180]  D. Choi,et al.  AMPA receptor activation potentiates zinc neurotoxicity , 1993, Neuron.

[181]  Jeffrey L. Saver,et al.  Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.

[182]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[183]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[184]  R. Rothlein,et al.  Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.

[185]  R. Harbaugh,et al.  Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. , 1996, Journal of neurosurgery.

[186]  A. Clark,et al.  Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia , 1997, Neuroscience Letters.

[187]  C. Prosser,et al.  COMPARATIVE ANIMAL PHYSIOLOGY , 1962 .

[188]  J. Thiran,et al.  Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.

[189]  R. Sacco,et al.  Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis , 2002, Stroke.

[190]  M. Moskowitz,et al.  Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.

[191]  D. Corbett,et al.  Persistent Neuroprotection with Prolonged Postischemic Hypothermia in Adult Rats Subjected to Transient Middle Cerebral Artery Occlusion , 2000, Experimental Neurology.

[192]  J. Bogousslavsky,et al.  Do transient ischemic attacks have a neuroprotective effect? , 2000, Neurology.

[193]  F. Nicoletti,et al.  Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[194]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[195]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[196]  B. Lin,et al.  Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature Modulation , 1995, Journal of neurochemistry.

[197]  M. Mishina,et al.  Attenuation of Focal Ischemic Brain Injury in Mice Deficient in the ε1 (NR2A) Subunit of NMDA Receptor , 1998, The Journal of Neuroscience.

[198]  Jean-Philippe Thiran,et al.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.

[199]  D. W. Beck,et al.  Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.

[200]  J. Grotta,et al.  Stroke program review group: an interim report. , 2008, Stroke.

[201]  E. Lo Experimental models, neurovascular mechanisms and translational issues in stroke research , 2008, British journal of pharmacology.

[202]  A. Shuaib,et al.  Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate , 2000, Neuropharmacology.

[203]  D. Choi,et al.  NMDA receptor-mediated K+ efflux and neuronal apoptosis. , 1999, Science.

[204]  J. Wettstein,et al.  White matter ischaemia , 1999, Brain Research Reviews.

[205]  E. Connolly,et al.  Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. , 1997, Circulation research.

[206]  W. Paschen Role of calcium in neuronal cell injury: which subcellular compartment is involved? , 2000, Brain Research Bulletin.

[207]  S. Cramer,et al.  Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals , 2001, Stroke.

[208]  E. Tournier-Lasserve CACNA1A mutations , 1999, Neurology.

[209]  I. Ford,et al.  Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial , 2004, The Lancet.

[210]  R. Bullock,et al.  Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. , 1999, Journal of neurosurgery.

[211]  L. Goldstein,et al.  Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. , 2001, JAMA.

[212]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[213]  M. Luby,et al.  Acute Stroke Imaging Research Roadmap II , 2008, Stroke.

[214]  Weizhao Zhao,et al.  Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.

[215]  D. Krieger,et al.  Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke , 2001, Stroke.

[216]  M. Moskowitz,et al.  Upregulation of the Fas Receptor Death-Inducing Signaling Complex after Traumatic Brain Injury in Mice and Humans , 2002, The Journal of Neuroscience.

[217]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[218]  D. Newell,et al.  Combination Therapy with MK-801 and α-Phenyl-tert-butyl-nitrone Enhances Protection against Ischemic Neuronal Damage in Organotypic Hippocampal Slice Cultures , 1996, Experimental Neurology.

[219]  R. Auer,et al.  Eubaric hyperoxemia and experimental cerebral infarction , 2002, Annals of neurology.

[220]  J. Grotta Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole , 2001, Cerebrovascular Diseases.

[221]  F. Tortella,et al.  Delayed Secondary Phase of Peri-Infarct Depolarizations after Focal Cerebral Ischemia: Relation to Infarct Growth and Neuroprotection , 2003, The Journal of Neuroscience.

[222]  P. Weinstein,et al.  Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. , 1987, Neurosurgery.

[223]  J. Grotta,et al.  NXY-059 for acute ischemic stroke. , 2006, The New England journal of medicine.

[224]  E. Kanal,et al.  The Cortical Ischemic Core and Not the Consistently Present Penumbra Is a Determinant of Clinical Outcome in Acute Middle Cerebral Artery Occlusion , 2003, Stroke.

[225]  Rick M Dijkhuizen,et al.  Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke , 2002, Neurology.

[226]  C. Molina,et al.  Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. , 2003, Journal of neurosurgery.

[227]  H. Nawashiro,et al.  Preferential Conditions for and Possible Mechanisms of Induction of Ischemic Tolerance by Repeated Hyperbaric Oxygenation in Gerbil Hippocampus , 2001, Neurosurgery.

[228]  P. Lyden,et al.  Effects of hyperbaric oxygen on neurologic outcome for cerebral ischemia in rats. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[229]  S. Lipton,et al.  Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[230]  H. Reichmann,et al.  Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke , 2009, Stroke.

[231]  J. Ritter Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group. , 1992, Stroke.

[232]  R. Sacco,et al.  Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. , 2001, JAMA.

[233]  John H. Zhang,et al.  Inhibition of Apoptosis by Hyperbaric Oxygen in a Rat Focal Cerebral Ischemic Model , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[234]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[235]  A Gregory Sorensen,et al.  Assessing tissue viability with MR diffusion and perfusion imaging. , 2003, AJNR. American journal of neuroradiology.

[236]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[237]  N. Noshita,et al.  Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals , 2002, Stroke.

[238]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[239]  N. Lassen,et al.  TREATMENT OF FOCAL CEREBRAL ISCHEMIA WITH HYPERBARIC OXYGEN , 1964 .

[240]  G. Feuerstein,et al.  Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.

[241]  D. Choi,et al.  Ions, cell volume, and apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[242]  David A. Boas,et al.  Mild Induced Hypertension Improves Blood Flow and Oxygen Metabolism in Transient Focal Cerebral Ischemia , 2008, Stroke.

[243]  G Bernardi,et al.  Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.

[244]  Fuhai Li,et al.  Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. , 1997, Stroke.

[245]  J. Arenillas,et al.  Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment , 2001, Stroke.

[246]  H. Reulen,et al.  Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia , 1999, Brain Research.

[247]  M. Esiri,et al.  White Matter Damage Is Associated With Matrix Metalloproteinases in Vascular Dementia , 2001, Stroke.

[248]  Mathias Hoehn-Berlage,et al.  Potassium-Induced Cortical Spreading Depressions during Focal Cerebral Ischemia in Rats: Contribution to Lesion Growth Assessed by Diffusion-Weighted NMR and Biochemical Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[249]  J. Grotta,et al.  Lubeluzole in Acute Ischemic Stroke Treatment: A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo , 2000, Stroke.

[250]  S. Starkman,et al.  Physician-Investigator Phone Elicitation of Consent in the Field: A Novel Method To Obtain Explicit Informed Consent For Prehospital Clinical Research , 2006, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[251]  E. Lo,et al.  Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases , 2002, Journal of neuroscience research.

[252]  Guo-Yuan Yang,et al.  Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[253]  Christopher Putman,et al.  Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.

[254]  Tao Yang,et al.  Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination Therapy , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[255]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[256]  H. Weiss,et al.  Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. , 1990, Archives internationales de pharmacodynamie et de therapie.

[257]  Jun Chen,et al.  Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[258]  K. Hossmann Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[259]  G. Schlaug,et al.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.

[260]  Á. Chamorro Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.

[261]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[262]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.

[263]  D. Holtzman,et al.  Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury* , 2002, The Journal of Biological Chemistry.

[264]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[265]  H. Fukasawa,et al.  Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. , 1990, Surgical neurology.

[266]  R. Bammer,et al.  The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion , 2008, Stroke.

[267]  F. Welsh,et al.  Postischemic Hypothermia Fails to Reduce Ischemic Injury in Gerbil Hippocampus , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[268]  J. Ulatowski,et al.  A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.

[269]  M. Moskowitz,et al.  Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia , 2001, British journal of pharmacology.

[270]  M. Ross,et al.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[271]  John H. Zhang,et al.  Dual effect of HBO on cerebral infarction in MCAO rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[272]  M. Zeng,et al.  Fas-induced caspase denitrosylation. , 1999, Science.

[273]  R. R. Smith,et al.  Hyperbaric oxygen and cerebral infarction in the gerbil. , 1987, Surgical neurology.